Cogent BiosciencesCOGT +3.58%25 Market Cap is $6,426.35 Mil as of Jun. 24, 2026. GuruFocus rates COGT with a GF Score™ of 25/100. The stock has 3 warning signs investors should review. Among 1,430 Biotechnology companies, Cogent Biosciences ranks better than 95.66% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cogent Biosciences's share price for the quarter that ended in Mar. 2026 was $38.49. Cogent Biosciences's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 170.77 Mil. Therefore, Cogent Biosciences's market cap for the quarter that ended in Mar. 2026 was $6,573.09 Mil.
Cogent Biosciences's quarterly market cap
increased
from Sep. 2025 ($2,007.93 Mil) to Dec. 2025 ($5,718.01 Mil) and
increased
from Dec. 2025 ($5,718.01 Mil) to Mar. 2026 ($6,573.09 Mil).
Cogent Biosciences's annual market cap
increased
from Dec. 2023 ($506.41 Mil) to Dec. 2024 ($861.60 Mil) and
increased
from Dec. 2024 ($861.60 Mil) to Dec. 2025 ($5,718.01 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cogent Biosciences's Enterprise Value for Today is $5,863.37 Mil.
Cogent Biosciences (NAS:COGT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Cogent Biosciences Market Cap Related Terms
Cogent Biosciences Market Cap Historical Data
* Premium members only.
The historical data trend for Cogent Biosciences's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Cogent Biosciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cogent Biosciences Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Cogent Biosciences's Market Cap distribution charts can be found below:
* The bar in red indicates where Cogent Biosciences's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Cogent Biosciences's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cogent Biosciences (COGT) has a Market Cap of $6,426.35 Mil as of Jun. 24, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cogent Biosciences and its competitors. According to the industry distribution chart, Cogent Biosciences ranks #62 out of 1430 companies in the Biotechnology industry, placing it in the top 4.3%.
Is Cogent Biosciences' Market Cap too high?
Cogent Biosciences' current Market Cap is $6,426.35 Mil. The Biotechnology industry median Market Cap is 117.26. Cogent Biosciences' value of $6,426.35 Mil is 5380.3% above this industry median. Based on the distribution chart, Cogent Biosciences ranks #62 out of 1430 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Cogent Biosciences has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Cogent Biosciences' Market Cap compare to SRRK and RYTM?
According to the Biotechnology industry distribution chart, Cogent Biosciences ranks #62 out of 1430 companies for Market Cap. This places Cogent Biosciences in the top 4% of its industry — outperforming the majority of peers. The industry median Market Cap is 117.26. Cogent Biosciences' value of $6,426.35 Mil is 5380.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 117.26, based on 1,430 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cogent Biosciences's current Market Cap of $6,426.35 Mil is 5380.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cogent Biosciences and its competitors. For the Biotechnology industry, the median Market Cap is 117.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cogent Biosciences's current Market Cap is $6,426.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cogent Biosciences stock overvalued right now?
Cogent Biosciences (COGT) has a current Market Cap of $6,426.35 Mil. The current Market Cap is $6,426.35 Mil and 5380.3% above the Biotechnology industry median of 117.26. Cogent Biosciences' overall GF Score™ is 25/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Cogent Biosciences (COGT), the current Market Cap is $6,426.35 Mil as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
25GF Score
Get the complete analysis for COGT
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COGT has been successfully added to your 
